Evidence map›Paper›PMID 39282148›Full record

ArticleOxidative medicine and cellular longevity2022

Triptonide Inhibits the Cervical Cancer Cell Growth via Downregulating the RTKs and Inactivating the Akt-mTOR Pathway.

Li-Na Zhou, Shi-Qing Peng, Xue-Lian Chen, Xiao-Ren Zhu, An-Qi Jin, Yuan-Yuan Liu, Li-Xia Zhu, Ya-Qun Zhu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oxidative medicine and cellular longevity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Li-Na ZhouDepartment of Radiotherapy & Oncology, The Second Affiliated Hospital of Soochow University, Institute of Radiation Oncology, Soochow University, 215004 Suzhou, China.ORCID https://orcid.org/0000-0002-1813-4432
Shi-Qing PengDepartment of Radiotherapy and Oncology, Affiliated Kunshan Hospital of Jiangsu University, 215300 Kunshan, China.ORCID https://orcid.org/0000-0002-8419-8039
Xue-Lian ChenDepartment of Radiology, Affiliated Kunshan Hospital of Jiangsu University, Kunshan 215300, China.ORCID https://orcid.org/0000-0002-5461-6105
Xiao-Ren ZhuDepartment of Radiotherapy and Oncology, Affiliated Kunshan Hospital of Jiangsu University, 215300 Kunshan, China.ORCID https://orcid.org/0000-0003-4784-3876
An-Qi JinDepartment of Radiotherapy and Oncology, Affiliated Kunshan Hospital of Jiangsu University, 215300 Kunshan, China.ORCID https://orcid.org/0000-0002-6064-5789
Yuan-Yuan LiuClinical Research and Lab Center, Affiliated Kunshan Hospital of Jiangsu University, 215300 Kunshan, China.ORCID https://orcid.org/0000-0001-8351-4282
Li-Xia ZhuDepartment of Gynaecology and Obstetrics, Affiliated Kunshan Hospital of Jiangsu University, 215300 Kunshan, China.ORCID https://orcid.org/0000-0003-4565-8511
Ya-Qun ZhuDepartment of Radiotherapy & Oncology, The Second Affiliated Hospital of Soochow University, Institute of Radiation Oncology, Soochow University, 215004 Suzhou, China.ORCID https://orcid.org/0000-0002-0952-7517

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The high incidence and mortality of cervical cancer (CC) require an urgent need for exploring novel valuable therapeutics. Triptonide (TN) is a small molecule monomer extracted from the Chinese herb

Identifiers

PMID39282148
PMCPMC11401660

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.